ArticleCureus2025
Primary Ovarian Leiomyosarcoma: A Case Report and Review of the Literature.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Primary ovarian leiomyosarcoma in a woman in her 70s: A case report.Case reports in women's health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Leiomyosarcoma, a rare malignant mesenchymal tumor originating from smooth muscle, comprises a small proportion of all ovarian malignancies and presents as an aggressive ovarian tumor. This case report presents a 56-year-old postmenopausal woman diagnosed with ovarian leiomyosarcoma (OLMS). The patient presented with chronic pelvic pain, abdominal distension, and metrorrhagia. Physical examination revealed a 12 cm pelvic mass in the right adnexal region. The surgical intervention included total hysterectomy with bilateral adnexectomy, bilateral pelvic and para-aortic lymphadenectomy, and total omentectomy, confirming leiomyosarcoma via histopathological analysis. The literature review underscores the absence of established pathogenesis for primary ovarian leiomyosarcoma (POLMS), highlighting diagnostic challenges due to the lack of specific tumor markers and ambiguous imaging results. Despite aggressive management, POLMS exhibits a poor prognosis for advanced tumors. Given the rarity of reported cases and the limited understanding of optimal management strategies, this report seeks to improve knowledge of the diagnostic challenges and therapeutic approaches for OLMS, emphasizing its atypical presentation and treatment considerations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.